Stock Comments / EPS Changes
Aegerion Pharmaceuticals (AEGR) 12-month price target was lowered at Jefferies to $80. Driven by lowered revisions on Juxtapid sales. Buy rating.
Amgen (AMGN) 12-month price target was raised at Jefferies to $145. Driven by increased evolocumab sales estimates, Jefferies said. Buy rating.
On Assignment (ASGN) 12-month price target was raised at Jefferies. Pushing into high-margin perm recruiting biz with strong management track record capable of delivering long-term targets, Jefferies said. Twelve-month price target is $42. Buy rating.Lululemon Athletica (LULU) 12-month price target was raised at UBS. Positive double-digit comps, above-plan performance in new stores and probable acceleration in international growth, UBS said. Twelve-month price target is $52. Neutral rating. (MU) estimates, 12-month price target were cut at Bank of America/Merrill Lynch. Shares are now seen reaching $19.10. Estimates were also cut, given lower memory prices, Bank of America/Merrill said. Underperform rating. Plains GP Holding (PAGP) 12-month price target was raised at UBS to $32. Driven by oil infrastructure expansions, UBS said. Buy rating. Red Hat (RHT) 12-month price target was raised at UBS to $64. High interest in OpenStack and strong cross-sell, UBS said. Buy rating. Teva (TEVA) was added to the US Focus List at Citigroup. Twelve-month price target is $60. Company offers the best risk/reward of the group, Citigroup said. VMware (VMW) 12-month price target was increased at Jefferies to $124. Driven by vSAN product growth as it lowers storage costs and simplifies storage management, Jefferies said. Buy rating. Follow TheStreet on Twitter and become a fan on Facebook
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV